2-bromo-5,3'-bipyridine | 1088410-80-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-bromo-5,3'-bipyridine
• 英文别名: 2-bromo-5-(3-pyridyl)pyridine；6-bromo-3,3'-bipyridine；2-Bromo-5-(pyridin-3-yl)pyridine；2-bromo-5-pyridin-3-ylpyridine
• CAS: 1088410-80-3
• 化学式: C₁₀H₇BrN₂
• 分子量: 235.083
• InChiKey: IGESWGAGVGFDEU-UHFFFAOYSA-N

物化性质

• 沸点：
  360.6±27.0 °C(Predicted)
• 密度：
  1.493±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-bromo-5,3'-bipyridine 、 对氟苯乙醇 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.33h， 以40%的产率得到6-(4-fluorophenethoxy)-3,3′-bipyridine
  参考文献：
  名称：

  Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1

  摘要：

  DOI：

  10.1021/acs.jmedchem.1c00948

文献信息

• 红色磷光化合物和使用该化合物的有机发光二 极管器件
  申请人：乐金显示有限公司

  公开号：CN103896920B

  公开（公告）日：2016-08-17

  本发明涉及一种红色磷光化合物和使用该化合物的有机发光二极管器件。本发明提供下式之一的红色磷光化合物：
• LINCOSAMIDE DERIVATIVES AND ANTIMICROBIAL AGENTS COMPRISING THE SAME AS ACTIVE INGREDIENT
  申请人：Umemura Eijirou

  公开号：US20100184746A1

  公开（公告）日：2010-07-22

  An objective of the present invention is to provide compounds of formula (I) or their pharmacologically acceptable salts or solvates wherein A represents aryl while R 1 represents a five- or six-membered monocyclic heterocyclic group, or A represents a four- to six-membered monocyclic heterocyclic group while R 1 represents aryl or a five- or six-membered monocyclic heterocyclic group; R 2 represents a hydrogen atom or C 1-6 alkyl; R 3 represents C 1-6 alkyl or C 3-6 cycloalkyl-C 1-4 alkyl; R 4 , R 5 , and R 6 represent a hydrogen atom; R 7 represents C 1-6 alkyl; and m is 1 to 3. The compounds are novel lincosamide derivatives that have a potent activity against resistant Streptococcus pneumoniae . Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.

  本发明的目标是提供式（I）的化合物或其药理学上可接受的盐或溶剂，其中A代表芳基，而R1代表五元或六元单环杂环基，或A代表四至六元单环杂环基，而R1代表芳基或五元或六元单环杂环基；R2代表氢原子或C1-6烷基；R3代表C1-6烷基或C3-6环烷基-C1-4烷基；R4、R5和R6代表氢原子；R7代表C1-6烷基；m为1至3。这些化合物是新型的林可霉素衍生物，对耐药性肺炎链球菌具有强效活性。此外，这些化合物可用作抗微生物剂，对预防或治疗细菌感染性疾病有用。
• RED PHOSPHORESCENT COMPOUND AND ORGANIC LIGHT EMITTING DIODE DEVICE USING THE SAME
  申请人：LG DISPLAY CO., LTD.

  公开号：US20140175402A1

  公开（公告）日：2014-06-26

  The present invention provides a phosphorescent compound of one of following formulas:

  本发明提供了以下公式之一的磷光化合物：
• LINCOSAMIDE DERIVATIVE, AND ANTIBACTERIAL AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT
  申请人：Meiji Seika Kaisha Ltd.

  公开号：EP2166015A1

  公开（公告）日：2010-03-24

  An objective of the present invention is to provide compounds of formula (I) or their pharmacologically acceptable salts or solvates wherein A represents aryl while R1 represents a five- or six-membered monocyclic heterocyclic group, or A represents a four- to six-membered monocyclic heterocyclic group while R1 represents aryl or a five- or six-membered monocyclic heterocyclic group; R2 represents a hydrogen atom or C1-6 alkyl; R3 represents C1-6 alkyl or C3-6 cycloalkyl-C1-4 alkyl; R4, R5, and R6 represent a hydrogen atom; R7 represents C1-6 alkyl; and m is 1 to 3. The compounds are novel lincosamide derivatives that have a potent activity against resistant Streptococcus pneumoniae. Further, the compounds are usable as antimicrobial agents and are useful for preventing or treating bacterial infectious diseases.

  本发明的目的是提供式(I)化合物或其药理学上可接受的盐或溶液，其中 A 代表芳基，而 R1 代表五元或六元单环杂环基团，或 A 代表四至六元单环杂环基团，而 R1 代表芳基或五元或六元单环杂环基团；R2代表氢原子或C1-6烷基；R3代表C1-6烷基或C3-6环烷基-C1-4烷基；R4、R5和R6代表氢原子；R7代表C1-6烷基；m为1至3。这些化合物是新型林可酰胺衍生物，对耐药性肺炎链球菌具有强效活性。此外，这些化合物还可用作抗菌剂，用于预防或治疗细菌感染性疾病。
• HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
  申请人：Lee Sun-Young

  公开号：US20130001522A1

  公开（公告）日：2013-01-03

  A heterocyclic compound represented by Formula 1 below and an organic light-emitting device including the same: wherein Formula 1 is defined as in the detailed description.